New

From idea to ETF portfolio in minutes. Build yours now →

Advertisement
Advertisement

WDNAvsETF 2ETF Comparison

ETF 1
WDNA

WisdomTree BioRevolution Fund

This fund is part of
BioTech & Genomics
-0.12%
VS
ETF 2

Choose a second ETF to run a side-by-side ETF comparison with WDNA, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

WDNA performance and flow charts

Performance

024681012%Mar 27Apr 6Apr 13Apr 20Apr 27

Cumulative Flows

Mar 27Apr 6Apr 13Apr 20Apr 27

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/27/2026
1M3MYTD1Y3Y5Y
Perf.
WDNA
ETF 2
+5.78%
-4.95%
+4.41%
+41.36%
+11.54%
n/a
Flows
WDNA
ETF 2
-–
-$357K
-$357K
-$357K
-$524K
-–
Volatility and drawdown
3M1Y3Y5Y
Volatility
WDNA
ETF 2
+24.01%
+26.79%
+24.80%
n/a
Max drawdown
WDNA
ETF 2
-10.14%
-11.90%
-37.80%
n/a
Max drawdown duration
WDNA
ETF 2
79d
95d
901d
n/a
Trading data

Create an account to view trading data

Join for free
WDNA
ETF 2
Last sale
4/28/2026 at 1:30 PM
$17.65
Previous close
04/27/2026
$17.70
Consolidated volume
04/27/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality

Replication data will be available soon

Advertisement
Main metrics
Last update 4/28/2026 at 1:30 PM
Live
Closed
WDNA
ETF 2
Last price
$17.65
1D performance
-0.28%
AuM$2.30 M
E/R0.45%
Characteristics
WDNA
ETF 2
Management strategyPassive
ProviderWisdomTree
BenchmarkWisdomTree BioRevolution Index
N° of holdings75
Asset classEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 3, 2021
ESGNo
Advertisement
Exposure

Countries

WDNA
USA
80.59%
Other
19.41%
ETF 2

Sectors

WDNA
Health Care
82.52%
Other
17.48%
ETF 2
Advertisement

Diversification

WDNA

Total weight of top 15 holdings out of 15

38.65%
ETF 2

Top 15 holdings

Data as of March 31, 2026
WDNA
MODERNA INC
4.49%
JOHNSON&JOHNSON
3.26%
UTD THERAPEUT
2.90%
PFIZER
2.82%
LILLY
2.65%
STOKE THERAPEUTICS INC
2.57%
NATERA
2.46%
AMGEN-T
2.43%
ASTRAZENECA
2.34%
AMICUS THERAPEUTICS
2.28%
TWIST BIOSCIENCE CORP
2.20%
BIONTECH SE ADR
2.09%
US86366E1064
2.09%
IONIS PHARMACEUTICALS INC
2.07%
GILEAD SCIENCES
2.00%
ETF 2
Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast